Drugs / LAS40468
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT02094274 | Nov 2013 → May 2014 | asthma | Almirall, S.A. | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | LAS40468 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02094274 ↗ |
| Route | Inhaled | “administered via Genuair® dry powder inhaler (DPI)” NCT02094274 ↗ |